Published on
November 24, 2021
- 15:00 GMT
Vimian Group partners with biotechnology company Angany Inc. to develop novel vaccines for allergy in companion animals
This partnership will focus on the development of novel vaccines for allergy and atopic dermatitis in companion animals using bioparticle based vaccines. PHOENIX, ARIZONA, UNITED STATES & STOCKHOLM, SWEDEN, November 24, 2021 /EINPresswire.com/ -- …
Distribution channels:
Business & Economy, Consumer Goods
...